Prostate Cancer - Results from #360

The 17-Gene Genomic Prostate Score® Test is Prognostic for Outcomes after Primary External Beam Radiation Therapy in Men with Clinically Localized Prostate Cancer. November 1, 2022

Molecular Mechanisms of Castrate-Resistant Prostate Cancer. November 1, 2022

Impact of choosing wisely on imaging in men with newly diagnosed prostate cancer. November 1, 2022

Testosterone Therapy and Prostate Cancer: Incorporating Low-Level Evidence into Practical Recommendations. November 1, 2022

The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors. November 1, 2022

A Systematic Review to Evaluate Patient-Reported Outcome Measures (PROMs) for Metastatic Prostate Cancer According to the COnsensus-Based Standard for the Selection of Health Measurement INstruments (COSMIN) Methodology. November 1, 2022

Patterns of metastases progression- The linear parallel ratio. November 1, 2022

Movember Launches First of Its Kind Clinical Guidelines Driving Excellence in Sexual Health Care in Prostate Cancer October 31, 2022

Polygenic risk of any, metastatic, and fatal prostate cancer in the Million Veteran Program. October 31, 2022

Intermediate-term oncological outcomes after a negative endorectal coil multiparametric MRI of the prostate in patients without biopsy proven prostate cancer. October 31, 2022

Safety and Feasibility of Transperineal Targeted Microwave Ablation for Low- to Intermediate-risk Prostate Cancer. October 31, 2022

Safety and Survival Outcomes of Lutetium-177-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer with prior Radium-223 treatment: The RALU Study. October 31, 2022

Eligibility for 177Lu-PSMA therapy depends on the choice of companion diagnostic tracer: a comparison of 68Ga-PSMA-11 and 99mTc-MIP-1404 in metastatic castrate resistant prostate cancer. October 31, 2022

Maintaining bone health by estrogen therapy in patients with advanced prostate cancer: a narrative review. October 28, 2022

Survival analysis of localized prostate cancer with deep learning. October 28, 2022

Magnetic Resonance Imaging-based T-staging to Predict Biochemical Recurrence after Radical Prostatectomy: A Step Towards the iTNM Classification. October 28, 2022

A nomogram to predict pathologic T2 stage in candidates to robot-assisted radical prostatectomy with iT3 prostate cancer on preoperative multiparametric MRI: results from a multi-institutional collaboration. October 28, 2022

Association between age and efficacy of combination systemic therapies in patients with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysis. October 28, 2022

Cancer incidence and mortality in Australia from 2020 to 2044 and an exploratory analysis of the potential effect of treatment delays during the COVID-19 pandemic: a statistical modelling study. October 28, 2022

Heterogeneity and the tumor microenvironment in neuroendocrine prostate cancer. October 27, 2022

Page 19 of 1275

email news signup